Contribute

The inaugural Crohn’s & Colitis Congress™ (Jan. 18-20, 2018, Las Vegas, Nevada) gathered more than 1,250 inflammatory bowel disease (IBD) health care professionals and featured more than 250 abstracts — with the goal of advancing research and transforming the care of IBD patients. The Crohn’s & Colitis Congress is a new partnership between the Crohn’s […]

Inside AGA

For 2018, the Centers for Medicare and Medicaid Services (CMS) raised the bar for physicians and practices participating in the Merit-based Incentive Payment System (MIPS) under the Quality Payment Program (QPP), which was established under the Medicare Access and CHIP Reauthorization Act (MACRA). It will now be more difficult to earn the increasing number of […]

Quick Hits

The success of standard treatment for H.pylori has steadily declined. Increased use of antibiotics in foods and medical therapy may have contributed to increasing H. pylori antibiotic resistance.1 While there are some benefits of gastric colonization by H. pylori infection, it is still recognized as a carcinogen by the World Health Organization (WHO) and most […]

Inside AGA

“Equal pay for equal work,” is an expression that has resonated in our society since the early 20th century, evolving as the watchword for the women’s movement in post-war, industrial America. Women who were doing “men’s work” in the wartime workforce were devalued at war’s end. Confident in their abilities and empowered by the possibilities, […]

Quick Hits

Over the last 25 years of managing the care of patients and families with hereditary colorectal cancer syndromes (HCCS), I have witnessed many changes affecting both patients and practitioners. In particular, the discovery of new HCCS genes affords more patients and families a definitive cause for their disease. New technology for mutational analysis with next […]

Quick Hits

Chronic hepatitis C infection (HCV) is a major public health problem affecting more than 71 million patients worldwide including more than 3.5 million patients in the United States.1 With the introduction of direct acting antiviral agents (DAAs), it is now possible to cure hepatitis C infection even in patients with advanced fibrosis, cirrhosis and HCV […]

Debates

This is half of a two-part debate — read the opposing argument. The opinions expressed here are that of the author and do not represent the position of AGA. The past decade has witnessed numerous technical and technological advances in the field of colonoscopy. One of the most important developments, however, has been the realization […]